INS and Hypoglycemia: Such tailored adaptations would not only enhance the model’s generalizability but also promote the widespread use of dynamic insulin titration protocols, ultimately improving patient outcomes by reducing dosing variability and mitigating hyper- and hypoglycemia risk.